中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(8): 1802-1805

Rate of active immune response to hepatitis B vaccine in adult hepatitis B recipients after liver transplantation and its correlation with CD4 level before vaccination

DOI: 10.3969/j.issn.1001-5256.2021.08.012

  • Department of Infection and Liver Diseases, Peking University International Hospital, Beijing 102206, China

  • Received Date: 2021-01-14
  • Accepted Date: 2021-02-25
  • Published Date: 2021-08-20
    Abstract
  •   Objective  To investigate the main clinical influencing factors for the rate of active immune response to hepatitis B vaccine in adult hepatitis B recipients after liver transplantation.  Methods  Analysis was performed for the clinical follow-up data of 15 hepatitis B recipients after liver transplantation who received hepatitis B vaccine in Peking University International Hospital from May 2019 to November 2020, and all patients received liver transplantation at least 3 years before and had a CD4 level of 300-800 cells/u before vaccination. Each dose of vaccination was 40 μg recombinant hepatitis B vaccine (Saccharomyces cerevisiae), with a total of 4 injections at 0, 1, 6, and 8 months. Anti-HBs ≥100 mIU/L after four injections which lasted for 12 weeks without attenuation was considered successful response. Pearson correlation analysis and Kendall correlation analysis were used to investigate the correlation between CD4 level before vaccination and vaccine response rate; a linear regression analysis was used to investigate whether CD4 level before vaccination could predict the titer of anti-HBs after active vaccine immunization; a logistic regression analysis was used to investigate whether CD4 level before vaccination could predict vaccine response.  Results  Of all patients at week 12 of monitoring, 6 patients had response, among whom 1 had an anti-HBs level of > 1000 mIU/L and 5 had an anti-HBs level of ≥100 mIU/L, and the antibody titer did not attenuate till week 16; the response rate of hepatitis B vaccine was 40%. The 6 patients with response had a mean CD4 level of ≥592 cells/u before vaccination, while the 9 patients without response had a mean CD4 level of ≤500 cells/u before vaccination. CD4 level before vaccination was strongly correlated with the response rate of hepatitis B vaccine (Pearson correlation analysis: r=0.767, P=0.001; Kendall correlation: r=0.717, P=0.001).  Conclusion  CD4 level before vaccination is a key clinical factor affecting the response rate of hepatitis B vaccine after liver transplantation.

     

    • FullText(HTML)
  • loading
    • References(8)
  • [1]
    GUO Y, WANG WT, LI ZQ, et al. Hepatitis B vaccination: A new strategy to prevent hepatitis B recurrence after liver transplantation for hepatitis B virus-related recipients[J]. Chin J Hepatobiliary Surg, 2015, 21(10): 668-670. DOI: 10.3760/cma.j.issn.1007-8118.2015.10.006.

    郭源, 王文涛, 李自强, 等. 乙肝疫苗接种: 乙肝相关肝移植受者预防乙肝复发的新策略[J]. 中华肝胆外科杂志, 2015, 21(10): 668-670. DOI: 10.3760/cma.j.issn.1007-8118.2015.10.006.
    [2]
    SÁNCHEZ-FUEYO A, RIMOLA A, GRANDE L, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation[J]. Hepatology, 2000, 31(2): 496-501. DOI: 10.1002/hep.510310233.
    [3]
    BÁRCENA R, FERNANDEZ-BRASO M, URMAN J, et al. Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis[J]. Transplant Proc, 1999, 31(6): 2459-2460. DOI: 10.1016/s0041-1345(99)00417-0.
    [4]
    GARÇON N, van MECHELEN M. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems[J]. Expert Rev Vaccines, 2011, 10(4): 471-486. DOI: 10.1586/erv.11.29.
    [5]
    VANDEPAPELIÈRE P, HORSMANS Y, MORIS P, et al. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers[J]. Vaccine, 2008, 26(10): 1375-1386. DOI: 10.1016/j.vaccine.2007.12.038.
    [6]
    Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
    [7]
    BIENZLE U, GVNTHER M, NEUHAUS R, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease[J]. Hepatology, 2003, 38(4): 811-819. DOI: 10.1053/jhep.2003.50396.
    [8]
    DI PAOLO D, LENCI I, TRINITO MO, et al. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: Report of two successful cases[J]. Dig Liver Dis, 2005, 37(10): 793-798. DOI: 10.1016/j.dld.2005.01.023.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (448) PDF downloads(166) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return